STATE STREET CORP - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,518,711
-21.2%
1,506,237
-1.8%
0.00%
Q2 2023$5,734,497
-8.1%
1,533,288
-17.7%
0.00%
Q1 2023$6,242,179
-66.5%
1,863,337
-51.9%
0.00%
-100.0%
Q4 2022$18,640,962
+72.9%
3,875,460
+104.5%
0.00%0.0%
Q3 2022$10,781,000
-15.8%
1,894,736
+5.1%
0.00%0.0%
Q2 2022$12,804,000
-5.3%
1,803,368
-3.7%
0.00%0.0%
Q1 2022$13,516,000
-35.0%
1,872,074
-19.5%
0.00%0.0%
Q4 2021$20,790,000
-46.2%
2,325,453
+110.9%
0.00%
-50.0%
Q3 2021$38,666,000
+87.2%
1,102,852
+14.7%
0.00%
+100.0%
Q2 2021$20,659,000
+17.6%
961,767
+238.0%
0.00%0.0%
Q1 2021$17,569,000
+88.9%
284,523
+27.8%
0.00%0.0%
Q4 2020$9,303,000222,6740.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$17,648,0002.07%
EcoR1 Capital, LLC 6,340,639$45,019,0001.55%
CM Management, LLC 200,000$1,420,0001.51%
K2 PRINCIPAL FUND, L.P. 1,606,059$11,403,0001.26%
Cormorant Asset Management, LP 1,547,181$10,985,0000.83%
Privium Fund Management (UK) Ltd 61,284$435,0000.49%
Atom Investors LP 30,911$219,0000.10%
FEDERATED HERMES, INC. 3,588,131$25,476,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 347,612$2,468,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 1,799,507$12,777,0000.04%
View complete list of ATEA PHARMACEUTICALS INC shareholders